MJR

MJR is an international, peer-reviewed platinum open access journal aims to publish innovative evidence-based articles in all fields of the rheumatic diseases.

[MJR @MJR_journal]

🎉 Big milestone for the Mediterranean Journal of Rheumatology!
We are proud to announce our first-ever Impact Factor: 1.4 (JCR 2024) 📊✨
This achievement reflects the dedication of our authors, reviewers, and editorial team — thank you for being part of this journey!

[MJR @MJR_journal]

Mediterranean Journal of Rheumatology: Special Issue on Spondylarthritis - https://t.co/lm8nO4EtRd

[MJR @MJR_journal]

The MJR September 2025 Issue is online! - https://t.co/AX8xWaLvAQ

[MJR @MJR_journal]

Rheumatoid lung disease — often underrecognized!
👉https://t.co/7e96B7QbOb
🧩 Affects airways, parenchyma & pleura
🚬 Smoking = key trigger via citrullination
💡 Early screening (HRCT, PFT, US) is vital
🎯 Multidisciplinary care improves outcomes

[MJR @MJR_journal]

📰 New issue alert!
The latest @MJR_journal is out!
👉https://t.co/ESST6RAl0x
Autoimmunity, imaging, biomarkers & expert reviews — don’t miss it!

[MJR @MJR_journal]

🌿 On #WorldArthritisDay,
MJR 👉https://t.co/ESST6RzNaZ stands with people living with #arthritis worldwide.
Through #OpenAccess, collaborative research, we aim to improve care and quality of life for all patients.
#Rheumatology #PatientCare

[MJR @MJR_journal]

🧠 State of the art in #RA treatment
New review summarizes evolving strategies in rheumatoid arthritis management:
💊 DMARDs remain the cornerstone
🧬 Biologics & JAK inhibitors revolutionized care
🎯 Personalized, mechanism-based therapy is the future
👉https://t.co/IIVyyjEqeU

[MJR @MJR_journal]

Check out the latest issue of MJR!!
🔹 Infrared Thermography in RMDs
🔹 Cortisol & RA outcomes
🔹 Anti-TIF1γ myositis
🔹 What do rheumatologists know about reproductive health?
and much more!!

[MJR @MJR_journal]

The MJR June 2025 Issue is online! - https://t.co/PqzIPoSLZc

[MJR @MJR_journal]

Exciting news for the MJR: The JCR 2024 Impact Factors are out! - https://t.co/pUGK2m5XOB

[MJR @MJR_journal]

🆕 Physical modalities for #fibromyalgia pain relief
💡 Review highlights:
🔹 Exercise
🔹 Hydrotherapy
🔹 TENS
🔹 Low-level laser & magnetic therapy
📌 Safe non-pharma options for FM care
👉https://t.co/0OMvFzoedY

[MJR @MJR_journal]

📌 What happens when #Fibromyalgia meets #pregnancy?
✅ Symptom worsening (pain, anxiety, depression)
✅ Higher rates of gestational diabetes
✅ Mixed findings on neonatal outcomes (prematurity, low Apgar)
Read more
👉https://t.co/VuI0K0alJz

[MJR @MJR_journal]

Starting #apremilast in #PsA?
This new multicentre real-world study shows that baseline musculoskeletal #ultrasound helps select better responders, improving drug retention.
👉https://t.co/MWSjSa2jXu

[MJR @MJR_journal]

🧡 World AS Day – 3 May 2025 #worldasday2025
Even simple tasks, like tying shoelaces, can be a challenge for those living with #axSpA
We join the #LaceUpForAxSpA campaign and invite you to explore our special issue dedicated to axSpA 👉https://t.co/QlqlmIh1lY

[MJR @MJR_journal]

The MJR March 2025 Issue is online! - https://t.co/ekjlhmYmzq

[MJR @MJR_journal]

🔥New Issue Alert!
The March 2025 issue is out now! https://t.co/9jz2WroLdu
In this issue:
✅Pregnancy & Fibromyalgia
✅HLA-DRB1* & Autoimmune Skin Disorders
✅ Physical modalities for Pain therapies in Fibromyalgia
✅AI in Autoimmunity
✅Diet & Inflammation
& more

[MJR @MJR_journal]

Only 48% of Greek patients with rheumatic diseases know what biosimilars are, and 81% want more info.
📊 Survey of 309 patients reveals major knowledge gaps and concerns about safety & efficacy.
🧠 Urgent need for patient education!
https://t.co/CLG5vfWgzE

[MJR @MJR_journal]

Oral Hyaluronic Acid in #Osteoarthritis & Low Back Pain
🔹 11 studies, 597 patients
🔹 80% showed improvement in pain & function
🔹 Safe, well-tolerated alternative to injections
👉https://t.co/T402TYSALO

[MJR @MJR_journal]

iTNFα vs. Newer Therapies in #SpA
✅ iTNFα inhibitors work across all SpA types
✅ IL-17i help #axSpA & #PsA but may worsen #IBD
✅ IL-12/IL-23i aid PsA & IBD but not axSpA
✅ JAKi show promise, but caution in elderly
👉https://t.co/AAjFmLjabV

[MJR @MJR_journal]

A new study on Anti-MDA5 Antibody-Associated RP-ILD
⚠️ High mortality risk—early intervention is key
✅ Early detection improves outcomes
📊 High ferritin & LDH predict poor prognosis
💊 Mixed results with combination therapy
👉https://t.co/fjuZXKU85C